1. Home
  2. SOLS vs MEDP Comparison

SOLS vs MEDP Comparison

Compare SOLS & MEDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

SOLS

Solstice Advanced Materials Inc.

N/A

Current Price

$81.84

Market Cap

12.7B

Sector

Industrials

ML Signal

N/A

Logo Medpace Holdings Inc.

MEDP

Medpace Holdings Inc.

HOLD

Current Price

$419.81

Market Cap

11.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SOLS
MEDP
Founded
2025
1992
Country
United States
United States
Employees
4400
N/A
Industry
Aerospace
Biotechnology: Commercial Physical & Biological Resarch
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
12.7B
11.7B
IPO Year
N/A
2016

Fundamental Metrics

Financial Performance
Metric
SOLS
MEDP
Price
$81.84
$419.81
Analyst Decision
Buy
Hold
Analyst Count
4
12
Target Price
$79.25
$473.17
AVG Volume (30 Days)
1.6M
451.2K
Earning Date
05-06-2026
04-22-2026
Dividend Yield
0.39%
N/A
EPS Growth
N/A
20.98
EPS
N/A
4.28
Revenue
N/A
N/A
Revenue This Year
$6.36
$13.19
Revenue Next Year
$5.64
$7.75
P/E Ratio
$54.31
$96.40
Revenue Growth
N/A
N/A
52 Week Low
$40.43
$284.10
52 Week High
$84.44
$628.92

Technical Indicators

Market Signals
Indicator
SOLS
MEDP
Relative Strength Index (RSI) 57.33 37.09
Support Level $77.82 $382.68
Resistance Level $83.53 $485.13
Average True Range (ATR) 3.06 17.73
MACD -0.36 -11.32
Stochastic Oscillator 74.78 29.20

Price Performance

Historical Comparison
SOLS
MEDP

About SOLS Solstice Advanced Materials Inc.

Solstice Advanced Materials is a diversified specialty chemicals company created in late 2025 after being spun off from Honeywell. It sells chemicals and materials to a wide range of end markets. Its largest product category is refrigerants used in heating, ventilation and air conditioning systems, and autos, where Solstice sells low global warming potential refrigerants. The company also sells materials used for building and construction, semiconductor production, healthcare packaging, and defense. Additionally, Solstice runs the only US uranium conversion business currently in operation.

About MEDP Medpace Holdings Inc.

Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.

Share on Social Networks: